These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26968331)

  • 1. Dose site reactions and related findings after vaccine administration in safety studies.
    Baldrick P
    J Appl Toxicol; 2016 Aug; 36(8):980-90. PubMed ID: 26968331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant.
    HogenEsch H; Dunham A; Burlet E; Lu F; Mosley YC; Morefield G
    J Appl Toxicol; 2017 Feb; 37(2):222-230. PubMed ID: 27241723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies.
    Destexhe E; Prinsen MK; van Schöll I; Kuper CF; Garçon N; Veenstra S; Segal L
    J Pharmacol Toxicol Methods; 2013; 68(3):367-73. PubMed ID: 23624216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergy.
    Baldrick P; Richardson D; Woroniecki SR; Lees B
    J Appl Toxicol; 2007; 27(4):399-409. PubMed ID: 17299813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study designs for the nonclinical safety testing of new vaccine products.
    Forster R
    J Pharmacol Toxicol Methods; 2012 Jul; 66(1):1-7. PubMed ID: 22561062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity.
    Mancebo A; Casacó A; González B; Ledón N; Sorlozabal J; León A; Gómez D; González Y; Bada AM; González C; Arteaga ME; Ramírez H; Fuentes D
    Vaccine; 2012 May; 30(22):3329-38. PubMed ID: 22433960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of L-tyrosine confirming its safe human use as an adjuvant.
    Baldrick P; Richardson D; Wheeler AW
    J Appl Toxicol; 2002; 22(5):333-44. PubMed ID: 12355563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-clinical safety assessment of single and repeated intramuscular administration of a human papillomavirus-16/18 vaccine in rabbits and rats.
    Segal L; Morelle D; Kaaber K; Destexhe E; Garçon N
    J Appl Toxicol; 2015 Dec; 35(12):1577-85. PubMed ID: 25752809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
    Keitel W; Groth N; Lattanzi M; Praus M; Hilbert AK; Borkowski A; Tsai TF
    Vaccine; 2010 Jan; 28(3):840-8. PubMed ID: 19835829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
    Rüttinger D; van den Engel NK; Winter H; Schlemmer M; Pohla H; Grützner S; Wagner B; Schendel DJ; Fox BA; Jauch KW; Hatz RA
    J Transl Med; 2007 Sep; 5():43. PubMed ID: 17868452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immunotoxicity reactions induced by adjuvanted vaccines.
    Batista-Duharte A; Portuondo D; Pérez O; Carlos IZ
    Int Immunopharmacol; 2014 May; 20(1):170-80. PubMed ID: 24607449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond antigens and adjuvants: formulating future vaccines.
    Moyer TJ; Zmolek AC; Irvine DJ
    J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
    Herzog C
    Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.
    Petrovsky N
    Drug Saf; 2015 Nov; 38(11):1059-74. PubMed ID: 26446142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL) for the treatment of grass pollen allergy.
    Baldrick P; Richardson D; Wheeler AW; Woroniecki SR
    J Appl Toxicol; 2004; 24(4):261-8. PubMed ID: 15300713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.
    Huntimer L; Ramer-Tait AE; Petersen LK; Ross KA; Walz KA; Wang C; Hostetter J; Narasimhan B; Wannemuehler MJ
    Adv Healthc Mater; 2013 Feb; 2(2):369-78. PubMed ID: 23184561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
    Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L
    Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.